Clinical Potential of Omega-3 Fatty Acids in the Treatment of Schizophrenia

ISSN： 1172-7047

Source： CNS Drugs, Vol.17, Iss.15, 2003-01, pp. : 1081-1091

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders

By Peet Malcolm Stokes Caroline

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1051-1059

Adis International

Access to resources Recommend Favorite

N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 450-459

Bentham Science Publishers

Access to resources Recommend Favorite

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 663-680

Bentham Science Publishers

Access to resources Recommend Favorite

Omega-3 Fatty Acids and Hippocampal Neurogenesis in Depression

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 460-465

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Omega-3 Fatty Acids on Osteoporosis

Current Pharmaceutical Design, Vol. 15, Iss. 36, 2009-12 ,pp. : 4157-4164

Bentham Science Publishers

Access to resources Recommend Favorite